2026 Global: Balloon-Expandable Vascular Stent Market -Competitive Review (2032) report
Description
The 2026 Global: Balloon-Expandable Vascular Stent Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Abbott Vascular, based in Abbott Park, Illinois, United States, is a leading supplier of balloon expandable coronary stents with a broad global footprint spanning North America, Europe, and Asia. Boston Scientific, headquartered in Marlborough, Massachusetts, United States, remains a major force in the balloon expandable segment, offering a wide portfolio of stent platforms used in interventional cardiology worldwide. Medtronic, with its corporate headquarters in Dublin, Ireland, sustains a significant presence in the vascular stent market through balloon expandable designs employed across diverse clinical settings. Biotronik, founded in Berlin, Germany, markets a comprehensive line of balloon expandable stents and related cardiovascular devices, with a strong footprint in Europe and expanding activity in Asia and the Americas. Collectively these four companies drive a substantial share of supply for modern balloon expandable stents in mature markets, underpinned by ongoing investments in deliverability, radiopacity, and polymer technologies to address complex lesions in interventional cardiology.
Terumo, headquartered in Tokyo, Japan, is a longstanding participant in the balloon expandable stent market, leveraging its global distribution and robust manufacturing network across Asia-Pacific and other regions. Lepu Medical Technology Co., Ltd., based in Beijing, China, has grown rapidly as a domestic supplier of balloon expandable coronary stents with increasing international reach through partnerships and export to Europe, Africa, and the Americas. MicroPort Scientific Corporation, with headquarters in Shanghai, China, has built a sizable global footprint through manufacturing and sales networks that span Asia, Europe, and the Americas, including balloon expandable stents used in a range of interventional procedures. Meril Life Sciences Pvt. Ltd., headquartered in Thane, Maharashtra, India, has developed and commercialized balloon expandable stents that have gained regulatory clearance in multiple markets and contribute to Asia-Pacific market share. Together these firms underscore the expansion of balloon-expandable stent manufacturing capacity in Asia and growing relevance to supply globally.
Medinol Ltd., based in Tel Aviv, Israel, is a historic innovator in coronary stents, with a portfolio of balloon-expandable designs that have influenced practice patterns across continents and regulatory environments. Biosensors International Group Ltd., headquartered in Singapore, operates a broad slate of stent platforms and related technologies marketed across Asia-Pacific and in selected global markets, contributing to competition in the balloon-expandable segment. Medinol and Biosensors sit among the niche and mid-scale players that complement the mass-market offerings from the larger groups, helping to drive innovation in deliverability, surface modification, and polymer coatings. Collectively these ten companies provide a global supply chain for balloon-expandable vascular stents, spanning North America, Europe, and Asia, and reflecting both mature markets and emerging economies. The market remains dynamic, with ongoing consolidation, regulatory evolution, and continued emphasis on safety and patient outcomes in interventional cardiology. Global collaboration and quality management will shape future innovation adoption worldwide.
Abbott Vascular, based in Abbott Park, Illinois, United States, is a leading supplier of balloon expandable coronary stents with a broad global footprint spanning North America, Europe, and Asia. Boston Scientific, headquartered in Marlborough, Massachusetts, United States, remains a major force in the balloon expandable segment, offering a wide portfolio of stent platforms used in interventional cardiology worldwide. Medtronic, with its corporate headquarters in Dublin, Ireland, sustains a significant presence in the vascular stent market through balloon expandable designs employed across diverse clinical settings. Biotronik, founded in Berlin, Germany, markets a comprehensive line of balloon expandable stents and related cardiovascular devices, with a strong footprint in Europe and expanding activity in Asia and the Americas. Collectively these four companies drive a substantial share of supply for modern balloon expandable stents in mature markets, underpinned by ongoing investments in deliverability, radiopacity, and polymer technologies to address complex lesions in interventional cardiology.
Terumo, headquartered in Tokyo, Japan, is a longstanding participant in the balloon expandable stent market, leveraging its global distribution and robust manufacturing network across Asia-Pacific and other regions. Lepu Medical Technology Co., Ltd., based in Beijing, China, has grown rapidly as a domestic supplier of balloon expandable coronary stents with increasing international reach through partnerships and export to Europe, Africa, and the Americas. MicroPort Scientific Corporation, with headquarters in Shanghai, China, has built a sizable global footprint through manufacturing and sales networks that span Asia, Europe, and the Americas, including balloon expandable stents used in a range of interventional procedures. Meril Life Sciences Pvt. Ltd., headquartered in Thane, Maharashtra, India, has developed and commercialized balloon expandable stents that have gained regulatory clearance in multiple markets and contribute to Asia-Pacific market share. Together these firms underscore the expansion of balloon-expandable stent manufacturing capacity in Asia and growing relevance to supply globally.
Medinol Ltd., based in Tel Aviv, Israel, is a historic innovator in coronary stents, with a portfolio of balloon-expandable designs that have influenced practice patterns across continents and regulatory environments. Biosensors International Group Ltd., headquartered in Singapore, operates a broad slate of stent platforms and related technologies marketed across Asia-Pacific and in selected global markets, contributing to competition in the balloon-expandable segment. Medinol and Biosensors sit among the niche and mid-scale players that complement the mass-market offerings from the larger groups, helping to drive innovation in deliverability, surface modification, and polymer coatings. Collectively these ten companies provide a global supply chain for balloon-expandable vascular stents, spanning North America, Europe, and Asia, and reflecting both mature markets and emerging economies. The market remains dynamic, with ongoing consolidation, regulatory evolution, and continued emphasis on safety and patient outcomes in interventional cardiology. Global collaboration and quality management will shape future innovation adoption worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
